Spinophilin loss contributes to tumorigenesis in vivo

Cell Cycle

Volumn 10, Issue 12, 2011, Pages 1948-1955

  Ferrer, Irene ^a,b   Peregrino, Sandra ^a   Cañamero, Marta ^a   Cecilia, Yolanda ^a   Blanco Aparicio, Carmen ^a   Carnero, Amancio ^a,c  

^a Structural Biology and Biocomputing Programme   (Spain)

^b CSIC   (Spain)

^c Instituto de Biomedicina de Sevilla   (Spain)

Author keywords

Cancer; Mouse model; p53; PPP1R9B; Spinophilin; Tumor suppressor

Indexed keywords

BRCA1 PROTEIN; PROTEIN P53; SCAFFOLD PROTEIN; SPINOPHILIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST DUCT; CANCER INCIDENCE; CELL PROLIFERATION; CHROMOSOME 17Q; CONTROLLED STUDY; FEMALE; GENE DOSAGE; GENE LOSS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LYMPHOMA; MALE; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN FUNCTION; SPN GENE; SURVIVAL; THYMOMA; TISSUE MICROARRAY; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE;

MUS;

EID: 79959204600     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.12.15798     Document Type: Article

References (37)

1. Allen PB, Ouimet CC, Greengard P. Spinophilin, a novel protein phosphatase 1 binding protein localized to dendritic spines. Proc Natl Acad Sci USA 1997; 94:9956-61. (Pubitemid 27408172)
2. Satoh A, Nakanishi H, Obaishi H, Wada M, Takahashi K, Satoh K, et al. Neurabin-II/spinophilin. An actin filament-binding protein with one pdz domain localized at cadherin-based cell-cell adhesion sites. J Biol Chem 1998; 273:3470-5. (Pubitemid 28109767)
3. Sarrouilhe D, di Tommaso A, Metaye T, Ladeveze V. Spinophilin: from partners to functions. Biochimie 2006; 88:1099-113.
4. Hsieh-Wilson LC, Allen PB, Watanabe T, Nairn AC, Greengard P. Characterization of the neuronal targeting protein spinophilin and its interactions with protein phosphatase-1. Biochemistry 1999; 38:4365-73.
5. Ouimet CC, Katona I, Allen P, Freund TF, Greengard P. Cellular and subcellular distribution of spinophilin, a PP1 regulatory protein that bundles F-actin in dendritic spines. J Comp Neurol 2004; 479:374-88. (Pubitemid 39453143)
6. Feng J, Yan Z, Ferreira A, Tomizawa K, Liauw JA, Zhuo M, et al. Spinophilin regulates the formation and function of dendritic spines. Proc Natl Acad Sci USA 2000; 97:9287-92. (Pubitemid 30626711)
7. Tsukada M, Prokscha A, Eichele G. Neurabin II mediates doublecortin-dephosphorylation on actin filaments. Biochem Biophys Res Commun 2006; 343:839-47.
8. Bielas SL, Serneo FF, Chechlacz M, Deerinck TJ, Perkins GA, Allen PB, et al. Spinophilin facilitates dephosphorylation of doublecortin by PP1 to mediate microtubule bundling at the axonal wrist. Cell 2007; 129:579-91. (Pubitemid 46660968)
9. Castro ME, Ferrer I, Cascon A, Guijarro MV, Lleonart M, Cajal SR, et al. PPP1CA contributes to the senescence program induced by oncogenic Ras. Carcinogenesis 2008; 29:491-9. (Pubitemid 351404864)
10. Ruiz L, Traskine M, Ferrer I, Castro E, Leal JF, Kaufman M, et al. Characterization of the p53 response to oncogene-induced senescence. PLoS ONE 2008; 3:3230.
11. Wang RH, Liu CW, Avramis VI, Berndt N. Protein phosphatase 1alpha-mediated stimulation of apoptosis is associated with dephosphorylation of the retinoblastoma protein. Oncogene 2001; 20:6111-22. (Pubitemid 32964423)
12. Nelson DA, Krucher NA, Ludlow JW. High molecular weight protein phosphatase type 1 dephosphorylates the retinoblastoma protein. J Biol Chem 1997; 272:4528-35. (Pubitemid 27078533)
13. Alberts AS, Thorburn AM, Shenolikar S, Mumby MC, Feramisco JR. Regulation of cell cycle progression and nuclear affinity of the retinoblastoma protein by protein phosphatases. Proc Natl Acad Sci USA 1993; 90:388-92. (Pubitemid 23028867)
14. 1 arrest in human cancer cells. Curr Biol 1997; 7:375-86.
15. Rubin E, Tamrakar S, Ludlow JW. Protein phosphatase type 1, the product of the retinoblastoma susceptibility gene and cell cycle control. Front Biosci 1998; 3:1209-19.
16. Narita M, Nunez S, Heard E, Lin AW, Hearn SA, Spector DL, et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003; 113:703-16. (Pubitemid 36724935)
17. Mooi WJ, Peeper DS. Oncogene-induced cell senescence - halting on the road to cancer. N Engl J Med 2006; 355:1037-46. (Pubitemid 44343547)
18. Molina-Pinelo S, Ferrer I, Blanco-Aparicio C, Peregrino S, Pastor MD, Vega JA, et al. Downregulation of spinophilin in lung tumors contributes to tumorigenesis. J of Pathol 2011; In press.
19. Porter DE, Steel CM, Cohen BB, Wallace MR, Carothers A, Chetty U, et al. Genetic linkage analysis applied to unaffected women from families with breast cancer can discriminate high- from low-risk individuals. Br J Surg 1993; 80:1381-5. (Pubitemid 23345092)
20. Porter DE, Cohen BB, Wallace MR, Smyth E, Chetty U, Dixon JM, et al. Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12-21. Br J Surg 1994; 81:1512-5. (Pubitemid 24306008)
21. Renner O, Blanco-Aparicio C, Grassow M, Canamero M, Leal JF, Carnero A. Activation of phosphatidylinositol-3-kinase by membrane localization of p110alpha predisposes mammary glands to neoplastic transformation. Cancer Res 2008; 68:9643-53.
22. Li B, Murphy KL, Laucirica R, Kittrell F, Medina D, Rosen JM. A transgenic mouse model for mammary carcinogenesis. Oncogene 1998; 16:997-1007. (Pubitemid 28107938)
23. INK4a. Cell 1997; 88:593-602.
24. Efeyan A, Garcia-Cao I, Herranz D, Velasco-Miguel S, Serrano M. Tumour biology: Policing of oncogene activity by p53. Nature 2006; 443:159. (Pubitemid 44387596)
25. Palmero I, Serrano M. Induction of senescence by oncogenic Ras. Methods Enzymol 2001; 333:247-56.
26. Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M, et al. Tumour biology: senescence in premalignant tumours. Nature 2005; 436:642. (Pubitemid 41117258)
27. De Marchis L, Cropp C, Sheng ZM, Bargo S, Callahan R. Candidate target genes for loss of heterozygosity on human chromosome 17q21. Br J Cancer 2004; 90:2384-9. (Pubitemid 38961904)
28. Tseng SL, Yu IC, Yue CT, Chang SF, Chang TM, Wu CW, et al. Allelic loss at BRCA1, BRCA2 and adjacent loci in relation to Tp53 abnormality in breast cancer. Genes Chromosomes Cancer 1997; 20:377-82.
29. Schmutzler RK, Homann A, Bierhoff E, Wiestler OD, von Daimling A, Krebs D. [Detection of genetic alterations in sporadic breast tumors]. Gynakol Geburtshilfliche Rundsch 1995; 35:63-7.
30. Cohen BB, Porter DE, Wallace MR, Carothers A, Steel CM. Linkage of a major breast cancer gene to chromosome 17q12-21: results from 15 Edinburgh families. Am J Hum Genet 1993; 52:723-9. (Pubitemid 23310139)
31. Smith SA, Easton DF, Ford D, Peto J, Anderson K, Averill D, et al. Genetic heterogeneity and localization of a familial breast-ovarian cancer gene on chromosome 17q12-q21. Am J Hum Genet 1993; 52:767-76. (Pubitemid 23310146)
32. Easton DF, Bishop DT, Ford D, Crockford GP. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1993; 52:678-701. (Pubitemid 23310135)
33. Querzoli P, Albonico G, di Iasio MG, Ferretti S, Rinaldi R, Cariello A, et al. Biophenotypes and survival of BRCA1 and Tp53 deleted breast cancer in young women. Breast Cancer Res Treat 2001; 66:135-42. (Pubitemid 32521419)
34. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel JS, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992; 356:215-21.
35. Blanco-Aparicio C, Perez-Gallego L, Pequeno B, Leal JF, Renner O, Carnero A. Mice expressing myrAKT1 in the mammary gland develop carcinogen-induced ER-positive mammary tumors that mimic human breast cancer. Carcinogenesis 2007; 28:584-94. (Pubitemid 46523354)
36. Chao SK, Horwitz SB, McDaid HM. Insights into 4E-BP1 and p53 mediated reguation of accelerated cell senescence. Oncotarget 2011; 2:89-98.
37. Kuntziger T, Landsverk HB, Collas P, Syljuasen RG. Protein phospatase 1 regulators in DNA damage signaling. Cell Cycle 2011; 10:1-7.